Participated · Seed · Jul 2026

Inner Logic develops a simulation and data platform that allows device manufacturers to design, test, and validate procedural devices across thousands of virtual patients grounded in real clinical and procedural data. The company’s infrastructure aims to shift exploratory device development from physical prototypes and cadaver labs into in silico testing to accelerate iteration and broaden patient coverage. Founders include CEO Tito Porras, MD; CTO Mathias Unberath, PhD; and Chief Robotics Officer Axel Krieger, PhD, who collectively have authored over 400 peer-reviewed publications and are named inventors on more than 40 patents. Inner Logic has demonstrated its technology by training AI in simulation for orthopedic trauma and deploying it successfully on real hardware and patient anatomy, and by completing key steps of an autonomous gallbladder removal in a live animal model. The company is positioning its platform to support the development and validation of intelligent and autonomous procedural systems as they move toward clinical deployment. The announced financial position includes an $11.5 million seed round to advance product development and scaling.

Led · Series A · Jun 2026

Upside pairs dedicated Care Guides (licensed social workers and housing specialists) with an AI-supported housing orchestration platform and a proprietary affordable housing inventory database to identify, engage, and stabilize members. The company operates in 10 states and serves Medicaid, Medicare Advantage, D-SNP, commercial, and employer-sponsored populations. Upside reports 90%+ enrollment among referred members, more than half of members stabilized within 90 days, and up to 4x ROI within 12 months, alongside industry-leading member satisfaction. In the past 18 months it has secured partnerships with more than 17 national, state and regional health plans and is supporting four of the largest national payers. Upside plans to expand nationally, deepen its AI workflows for acuity stratification, housing matching, and case management, and scale Care Guide capacity and partner operations. Founded in 2020 and headquartered in Fort Lauderdale, FL, the company is positioning to grow across Medicaid, Medicare Advantage, and employer markets simultaneously.

Participated · Seed · Apr 2026

Greatly Health offers a virtual platform that delivers evidence-based supportive therapies—live expert-led group sessions in exercise, yoga, tai chi, and mindfulness—alongside personalized care planning, symptom tracking, and ongoing coaching. Its program was developed and clinically validated at Memorial Sloan Kettering Cancer Center, where a randomized trial led by the company’s co-founders demonstrated substantial improvements in outcomes, including a 16% absolute survival benefit at two years and large reductions in hospitalizations and treatment disruptions. Greatly serves patients directly and via sponsored programs, including a partnership with a global life sciences company and a patient advocacy group supporting roughly 200 metastatic breast cancer patients. The company aims to expand access through partnerships with health plans, oncology providers, and life sciences firms, and to shift integrative oncology from out-of-pocket or philanthropy-funded care to a reimbursed component of standard cancer treatment. Financially, Greatly recently raised a $4 million seed round to support team growth, technology enhancements, and expansion of its clinical offerings.

Participated · Series A · Apr 2026

Photon builds a full-stack prescription infrastructure combining digital prescribing and routing infrastructure, a pharmacy network, and a consumer-facing marketplace that surfaces real-time price and stock information. The platform includes capabilities such as prior authorization and clinical decision support and relies on AI to process complex pharmacy, benefits, and formulary data in real time. Photon began in direct-to-consumer digital health and has expanded into health systems, integrating with in-house pharmacies and provider workflows. Since its founding in 2021, the company says it has helped millions of patients make more informed pharmacy decisions. Photon plans to deepen marketplace integrations and expand health system partnerships to increase in-house pharmacy utilization and reduce administrative burden across the medication journey.

Led · Series A · Apr 2026

Keebler Health builds an LLM-native platform that processes unstructured clinical documentation at scale to surface missed hierarchical condition category (HCC) coding opportunities and deliver actionable clinician insights at the point of care. The platform targets both retrospective and concurrent workflows to enable appropriate revenue capture without disrupting existing clinical operations. Keebler positions risk adjustment as its initial focus while planning to expand into broader population health use cases, Next Best Diagnostic Action, and compliance/audit workflows such as RADV audit readiness. The company was founded in 2023 by Isaac Park, Andrew Stickney, and Kevin Hill, PhD, with Terrell Bacchus, MD as founding CMO, and is headquartered in Durham, North Carolina. Financially, Keebler has raised $23 million to date, including the $16 million Series A announced in this round.